Guardant Health Inc [GH] stock prices are down -0.12% to $102.38 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The GH shares have gain 5.04% over the last week, with a monthly amount drifted -7.97%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Wolfe Research upgraded its rating to Outperform on September 25, 2025, and kept the price target unchanged to $75. Mizuho started tracking the stock assigning an Outperform rating and suggested a price target of $55 on April 10, 2025. Barclays initiated its recommendation with an Overweight and recommended $60 as its price target on January 23, 2025. Guggenheim upgraded its rating to Buy for this stock on June 28, 2024, but kept the price target unchanged to $36.
The stock price of Guardant Health Inc [GH] has been fluctuating between $29.91 and $112.43 over the past year. Currently, Wall Street analysts expect the stock to reach $114.09 within the next 12 months. Guardant Health Inc [NASDAQ: GH] shares were valued at $102.38 at the most recent close of the market. An investor can expect a potential return of 11.44% based on the average GH price forecast.
Analyzing the GH fundamentals
The Guardant Health Inc [NASDAQ:GH] reported sales of 902.57M for trailing twelve months, representing a surge of 38.50%. Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at -0.49%, Pretax Profit Margin comes in at -0.44%, and Net Profit Margin reading is -0.44%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is 1.52 and Total Capital is -0.43. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-3.67.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 101.51 points at the first support level, and at 100.65 for the second support level. However, for the 1st resistance point, the stock is sitting at 103.12, and for the 2nd resistance point, it is at 103.87.
Ratios To Look Out For
It’s worth pointing out that Guardant Health Inc [NASDAQ:GH]’s Current Ratio is 3.50. Also, the Quick Ratio is 3.12, while the Cash Ratio stands at 2.45. Considering the valuation of this stock, the price to sales ratio is 14.68.
Transactions by insiders
Recent insider trading involved Tariq Musa, Director, that happened on Dec 17 ’25 when 116.0 shares were sold. Co-Chief Executive Officer, Eltoukhy Helmy completed a deal on Dec 15 ’25 to sell 90565.0 shares. Meanwhile, Chief Technology Officer Chudova Darya sold 5451.0 shares on Dec 15 ’25.
